The complaint focuses on the alleged misrepresentations and omissions within the core offering documents, which led to a substantial loss of market capitalization: Hagens Berman is a global plaintiffs ...
Director Jeffrey Lightcap acquired 40,000 shares at $26.34 per share for a total transaction value of $1,053,680 on Dec. 16, 2025. The purchase increased direct holdings to 40,000 shares, representing ...
The complaint focuses on the alleged misrepresentations and omissions within the core offering documents, which led to a substantial loss of market capitalization: The articles, information, and ...
Photo Credit: Ritesh Agarwal, CEO and founder of Prism, spoke on-stage at Skift India Summit in Delhi-NCR in March 2024. Source: Skift. Skift The shareholders approval for Prism's IPO signals a ...
Fannie Mae and Freddie Mac are poised for a public IPO, likely in Q1 next year, following administration and Treasury guidance. Junior preferred shares, such as FNMAS, offer anti-dilution protection ...
The banner across Medline's homepage today reads, "We're public." It's a bit of an understatement. The Northfield-based global medical supplies company on Dec. 16 offered about 216 million shares at ...
Big Pharma-backed Aktis Oncology has announced plans to go public, in the latest encouraging sign for those betting on a resurgence in biotech IPOs next year. Aktis saw the likes of Bristol Myers ...
Chinese AI chip maker Shanghai Biren Technology seeks to raise up to about US$623 million in a Hong Kong initial public offering, laying the groundwork for what could be another strong year of ...
Chinese chipmakers are rushing to the IPO market, raising funds that are key to the nation’s goal of technological self-reliance and winning the global race on artificial intelligence. The surge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback